| Primary |
| Dysmenorrhoea |
40.5% |
| Drug Use For Unknown Indication |
25.8% |
| Menstrual Disorder |
8.9% |
| Muscle Spasms |
5.2% |
| Back Pain |
3.3% |
| Headache |
3.3% |
| Pain |
1.9% |
| Premenstrual Syndrome |
1.6% |
| Menstrual Discomfort |
1.2% |
| Accidental Drug Intake By Child |
0.9% |
| Analgesia |
0.9% |
| Product Used For Unknown Indication |
0.9% |
| Self Injurious Behaviour |
0.9% |
| Unevaluable Event |
0.9% |
| Abdominal Distension |
0.7% |
| Abdominal Pain Upper |
0.7% |
| Intentional Overdose |
0.7% |
| Menstrual Cramp |
0.7% |
| Hypersensitivity |
0.5% |
| Mood Altered |
0.5% |
|
| Vomiting |
17.1% |
| No Adverse Event |
14.5% |
| Dysmenorrhoea |
13.2% |
| Somnolence |
7.5% |
| Nausea |
5.7% |
| Dizziness |
3.9% |
| Urticaria |
3.9% |
| Drug Screen Positive |
3.5% |
| Feeling Jittery |
3.1% |
| Muscle Spasms |
3.1% |
| Syncope |
3.1% |
| Hypersensitivity |
2.6% |
| Insomnia |
2.6% |
| Menstrual Disorder |
2.6% |
| Palpitations |
2.6% |
| Headache |
2.2% |
| Pain |
2.2% |
| Tachycardia |
2.2% |
| Throat Tightness |
2.2% |
| Unevaluable Event |
2.2% |
|
| Secondary |
| Dysmenorrhoea |
56.1% |
| Back Pain |
8.5% |
| Drug Use For Unknown Indication |
7.9% |
| Menstrual Disorder |
7.3% |
| Muscle Spasms |
5.5% |
| Contraception |
2.4% |
| Menstrual Discomfort |
2.4% |
| Headache |
1.2% |
| Ischaemic Heart Disease Prophylaxis |
1.2% |
| Pain |
1.2% |
| Acne |
0.6% |
| Arthralgia |
0.6% |
| Cardiac Disorder |
0.6% |
| Depression |
0.6% |
| Diabetes Mellitus |
0.6% |
| Hypothyroidism |
0.6% |
| Migraine |
0.6% |
| Oral Contraception |
0.6% |
| Procedural Pain |
0.6% |
| Rheumatoid Arthritis |
0.6% |
|
| Vomiting |
13.8% |
| Dysmenorrhoea |
12.1% |
| Menstrual Disorder |
8.6% |
| No Adverse Event |
8.6% |
| Drug Ineffective |
6.9% |
| Dyspepsia |
5.2% |
| Melaena |
5.2% |
| Syncope |
5.2% |
| Diabetes Mellitus |
3.4% |
| Drug Screen Positive |
3.4% |
| Insomnia |
3.4% |
| Retching |
3.4% |
| Spinal Fracture |
3.4% |
| Stomach Discomfort |
3.4% |
| Suicidal Behaviour |
3.4% |
| Vital Functions Abnormal |
3.4% |
| Abdominal Pain |
1.7% |
| Bone Pain |
1.7% |
| Completed Suicide |
1.7% |
| Drug Interaction |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.2% |
| Depression |
9.3% |
| Dysmenorrhoea |
7.9% |
| Contraception |
7.3% |
| Drug Use For Unknown Indication |
6.6% |
| Pain |
6.6% |
| Acne |
4.6% |
| Multiple Sclerosis |
4.6% |
| Nausea |
4.0% |
| Vomiting |
4.0% |
| Type 1 Diabetes Mellitus |
2.6% |
| Headache |
2.0% |
| Hormone Level Abnormal |
2.0% |
| Premenstrual Syndrome |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Vaginitis Bacterial |
2.0% |
| Abdominal Pain |
1.3% |
| Anxiety |
1.3% |
| Hepatitis C |
1.3% |
| Hypertension |
1.3% |
|
| Pain |
15.2% |
| Nausea |
12.1% |
| Vomiting |
9.1% |
| Headache |
6.1% |
| Superior Sagittal Sinus Thrombosis |
6.1% |
| Treatment Noncompliance |
6.1% |
| Vision Blurred |
6.1% |
| Alopecia |
3.0% |
| Blood Pressure Increased |
3.0% |
| Chills |
3.0% |
| Contusion |
3.0% |
| Convulsion |
3.0% |
| Fibromyalgia |
3.0% |
| Flushing |
3.0% |
| Gastroschisis |
3.0% |
| Hunger |
3.0% |
| Hydrocele |
3.0% |
| Hyperhidrosis |
3.0% |
| Injection Site Pain |
3.0% |
| Injection Site Pruritus |
3.0% |
|
